HOME JOURNALS CONTACT

Journal of Medical Sciences

Year: 2008 | Volume: 8 | Issue: 2 | Page No.: 125-130
DOI: 10.3923/jms.2008.125.130
Study of Selenium Concentration in Patients with Newly Diagnosed Non-Hodgkin`s Lymphoma
Maha I. Esmaeel, Mohamed A. Ebrahim, Manal A. Salah-Eldin, Mohamed I. Esmaeel, Maha Abdallah, Soad M. Mosaad and Wafaa El-Sankary

Abstract: This study was designed to examine selenium concentrations in patients with newly diagnosed Non-Hodgkin`s Lymphoma (NHL) and the possible association between the levels of this trace element with clinical features of the disease. Also, to test the hypothesis that selenium concentration at presentation would predict for response to treatment. This study was carried out on fifty-patients with newly diagnosed NHL and 25 control subjects, blood samples were taken for measurement of selenium by spectrometry. In comparison to the control subjects the serum selenium level was significantly lower with NHL with a mean of 0.033 (SD, 0.1) vs 0.81 (SD, 0.05), p<0.001. The mean serum selenium was significantly lower in patients with poorer performance status (p = 0.03) and in patients with advanced stage (p = 0.02), but there was no significant relation to the aggressiveness of the disease. Serum albumin was the only parameter that showed a significant positive correlation with serum selenium. There was a trend for serum selenium level to be higher in patients who achieved CR, but the difference was not statistically significant (p = 0.1). Selenium may play a role in the pathogenesis and prognosis of patients with NHL. In this study; the level of selenium was found inversely associated with the clinical stage of the disease and the performance status and may predict for the response to treatment in aggressive lymphoma. The possible utility of measuring serum selenium in NHL deserves further evaluation in clinical trials.

Fulltext PDF

How to cite this article
Maha I. Esmaeel, Mohamed A. Ebrahim, Manal A. Salah-Eldin, Mohamed I. Esmaeel, Maha Abdallah, Soad M. Mosaad and Wafaa El-Sankary, 2008. Study of Selenium Concentration in Patients with Newly Diagnosed Non-Hodgkin`s Lymphoma. Journal of Medical Sciences, 8: 125-130.

Keywords: Selenium, Non-Hodgkin`s Lymphoma (NHL) trace element, pathogenesis and prognosis

REFERENCES
  • Aboul-Fadl, T., 2005. Selenium derivatives as cancer preventive agents. Curr. Med. Chem. Anticancer Agents, 5: 637-652.
    Direct Link    

  • Avanzini, P., M. Vinceti, F. Ilariucci, F. Masini, M. D`Incà and G. Vivoli, 1995. Serum selenium concentrations in patients with newly diagnosed lymphoid malignancies. Haematologica, 80: 505-511.
    PubMed    

  • Charalabopoulos, K., A. Kotsalos, A. Batistatou, A. Charalabopoulos, P. Vezyraki, D. Peschos, V. Kalfakakou and A. Evangelou, 2006. Selenium in serum and neoplastic tissue in breast cancer: Correlation with CEA. Br. J. Cancer, 95: 674-676.
    Direct Link    

  • Combs, G.F. and W.P. Gray, 1998. Chemopreventive agents: Selenium. Pharmacol. Ther., 79: 179-192.
    CrossRef    

  • Deagen, J.T., M.A. Beilstein and P.D. Whanger, 1991. Chemical forms of selenium containing proteins from human plasma. J. Inorg. Biochem., 41: 261-268.
    CrossRef    

  • Deffuant, C., P. Celerier, H.L. Boiteau, P. Litoux and B. Dreno, 1994. Serum selenium in melanoma and epidermotropic cutaneous T-cell lymphoma. Acta Derm. Venereol., 74: 90-92.
    PubMed    

  • El-Bayoumy, K., V. DeVita, S. Hellman and S.A. Rosenberg, 1991. The Role of Selenium in Cancer Prevention. In: Cancer Principles and Practice of Oncology, DeVita, V.T., S. Hellman and S.A. Rosenberg (Eds.). Lippincott, Philadelphia, pp: 1-15

  • Gopee, N.V., J. Victor, V.H. Johnson and R.P. Sharma, 2004. Sodium selenite-induced apoptosis in murine b-lymphoma cells is associated with inhibition of protein kinase C, Nuclear Factor kB and inhibitor of apoptosis protein. Toxicol. Sci., 78: 204-214.
    PubMed    

  • Kim, T., U. Jung, D.Y. Cho and A.S. Chung, 2001. Selenium-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells. Carcinogenesis, 22: 559-565.
    Direct Link    

  • Lajtman, Z., D. Nosso, Z. Romic, K. Trutin-Ostovic and D. Krpan, 1994. Laryngeal cancer and blood selenium levels. Eur. Arch. Otorhinolaryngol., 251: 170-172.
    CrossRef    

  • Lanfear, J., J. Fleming, L. Wu, G. Webster and P.R. Harrison, 1994. The selenium metabolite selenodiglutathione induces p53 and apoptosis: Relevance to the chemopreventive effects of selenium. Carcinogenesis, 15: 1387-1392.
    CrossRef    

  • Last, K., V. Cornelius, T. Delves, C. Sieniawska, J. Fitzgibbon, A. Norton, J. Amess, A. Wilson, A.Z.S. Rohatiner and T.A. Lister, 2003. Presentation serum selenium predicts for overall survival, dose delivery and first treatment response in aggressive non-Hodgkin’s lymphoma. J. Clin. Oncol., 21: 2335-2341.
    Direct Link    

  • Last, K., L.Maharaj, J. Perry, S. Strauss, J. Fitzgibbon, T.A. Lister and S. Joel, 2006. The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann. Oncol., 17: 773-779.
    Direct Link    

  • Li, H., M.J. Stampfer, E.L. Giovannucci, J.S. Morris, W.C. Willett, J.M. Gaziano and J.A. Ma, 2004. A prospective study of plasma selenium levels and prostate cancer risk. J. Natl. Cancer Inst., 96: 696-703.
    Direct Link    

  • Lu, J., M. Kaeck, C. Jiang, A.C. Wilson and H.J. Thompson, 1994. Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem. Pharmacol., 47: 1531-1535.
    CrossRef    

  • Nichol, C., J. Herdman, N. Sattar, P.J. St.J. O'Dwyer, D. O'Reilly, D. Littlejohn and G. Fell, 1998. Changes in the concentrations of plasma selenium and selenoproteins after minor elective surgery: Further evidence for a negative acute phase response. Clin. Chem., 44: 1764-1766.
    PubMed    

  • Overvad, K., P. Gron, O. Langhoff, U. Tarp, A. Foldspang and E.B. Thorling, 1991. Selenium in human mammary carcinogenesis: A case- referent study. Eur. J. Cancer Prev., 1: 27-30.
    PubMed    

  • Patrick, L., 2004. Selenium biochemistry and cancer: A review of the literature. Alter. Med. Rev., 9: 239-258.
    Direct Link    

  • Sanz Alaejos, M. and C. Diaz Romero, 1993. Urinary selenium concentrations. Clin. Chem., 39: 2040-2052.
    Direct Link    

  • Sinha, R., T.K. Said and D. Medina, 1996. Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett., 107: 277-284.
    CrossRef    

  • Soriano-Garcia, M., 2004. Organoselenium compounds as potential therapeutic and chemopreventive agents: A review. Curr. Med. Chem., 11: 1657-1669.
    Direct Link    

  • Stadtman, T.C., 1996. Selenocysteine. Annu. Rev. Biochem., 65: 83-100.
    PubMed    

  • Vanloon, J., 1987. Selected Methods of Trace Metal Analysis: Biological and Environmental Samples. John Wiley and Sons, New York, pp: 211-221

  • Wilson, A.C., H.J. Thompson, P.J. Schedin, N.W. Gibson and H.E. Ganther, 1992. Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage. Biochem. Pharmacol., 43: 1137-1141.
    CrossRef    

  • Zachara, B.A., E. Marchaluk-Wisniewska, A. Maciag, J. Pepliñski, J. Skokowski and W. Lambrecht, 1997. Decreased selenium concentration and glutathione peroxidase activity in blood and increase of these parameters in malignant tissue of lung cancer patients. Lung, 175: 321-332.
    CrossRef    

    • © Science Alert. All Rights Reserved